![Balamurali Ambati](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Aktive Positionen von Balamurali Ambati
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
iVeena Delivery Systems, Inc.
![]() iVeena Delivery Systems, Inc. Pharmaceuticals: MajorHealth Technology iVeena Delivery Systems, Inc. engages in the manufacture of eye drops. It develops ocular drug products that eliminate the need to apply eye drops and painful injections. The company was founded by Balamurali Ambati and is headquartered in Salt Lake, UT. | Direktor/Vorstandsmitglied | - | - |
Gründer | - | - | |
Präsident | - | - | |
Inflammasome Therapeutics, Inc.
![]() Inflammasome Therapeutics, Inc. BiotechnologyHealth Technology Inflammasome Therapeutics, Inc. develops therapies for prevalent and degenerative diseases. The American company was founded in 2016 by Jayakrishna Ambati and Paul Ashton. Paul Ashton has been the CEO since 2016. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Balamurali Ambati
Statistik
International
Vereinigte Staaten | 3 |
Operativ
Director/Board Member | 2 |
Founder | 1 |
President | 1 |
Sektoral
Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
iVeena Delivery Systems, Inc.
![]() iVeena Delivery Systems, Inc. Pharmaceuticals: MajorHealth Technology iVeena Delivery Systems, Inc. engages in the manufacture of eye drops. It develops ocular drug products that eliminate the need to apply eye drops and painful injections. The company was founded by Balamurali Ambati and is headquartered in Salt Lake, UT. | Health Technology |
Inflammasome Therapeutics, Inc.
![]() Inflammasome Therapeutics, Inc. BiotechnologyHealth Technology Inflammasome Therapeutics, Inc. develops therapies for prevalent and degenerative diseases. The American company was founded in 2016 by Jayakrishna Ambati and Paul Ashton. Paul Ashton has been the CEO since 2016. | Health Technology |
- Börse
- Insiders
- Balamurali Ambati
- Erfahrung